Medpace Holdings, Inc. (MEDP) Borrowing debt
- Total debt · latest quarter (USD): Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-12-31..
- Net cash · latest quarter: Value (m); Formula and calculation Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-12-31..
- Debt / assets · latest quarter: Value (m); Formula and calculation Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-12-31..
Borrowing debt
Overview →Financial period ending 2019-12-31; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Total debt · latest quarter (USD) | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted). Period ending 2019-12-31. Calculation unavailable: missing inputs remain (m). |
| Net cash · latest quarter | (m) | Cash and cash equivalents plus current marketable securities less interest-bearing debt; negative net cash is displayed as net debt. Period ending 2019-12-31. Calculation unavailable: missing inputs remain (m). |
| Debt / assets · latest quarter | (m) | Current and noncurrent long-term debt plus complete reported short-term borrowings (commercial paper alone when no complete total is admitted) / total assets. Period ending 2019-12-31. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Borrowing debt due within one year | (m) | Long-term Debt, Current Maturities |
| Borrowing debt due after one year | 0.00 USD | Long-term Debt, Excluding Current Maturities |
| Commercial paper | (m) | |
| Cash and current securities | (m) | Cash and Cash Equivalents, at Carrying Value |
| Borrowing debt | (m) | Long-term Debt, Current Maturities · Long-term Debt, Excluding Current Maturities |
| Total assets | 1.14B USD | Assets |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Total debt | Net cash / debt | Borrowing debt due within one year (USD) | Borrowing debt due after one year (USD) | Commercial paper (USD) | Cash and current securities (USD) | Total assets (USD) | Debt / assets |
|---|---|---|---|---|---|---|---|---|
| 2019-12-31 | (m) | (m) | (m) | $0.00 | (m) | (m) | $1.14B | (m) |
| 2019-09-30 | (m) | (m) | (m) | $0.00 | (m) | (m) | $1.07B | (m) |
| 2019-06-30 | (m) | (m) | (m) | $0.00 | (m) | (m) | $1.02B | (m) |
| 2019-03-31 | (m) | (m) | (m) | $55.78M | (m) | (m) | $1.01B | (m) |
| 2018-12-31 | (m) | (m) | $0.00 | $79.72M | (m) | (m) | $967.93M | (m) |
| 2018-09-30 | (m) | (m) | $0.00 | $113.69M | (m) | (m) | $949.84M | (m) |
| 2018-06-30 | (m) | (m) | $16.50M | $147.02M | (m) | (m) | $968.18M | (m) |
| 2018-03-31 | (m) | (m) | $16.50M | $181.07M | (m) | (m) | $973.02M | (m) |
| 2017-12-31 | (m) | (m) | $16.50M | $205.11M | (m) | (m) | $950.72M | (m) |
| 2017-09-30 | (m) | (m) | $15.47M | $169.15M | (m) | (m) | $948.88M | (m) |
| 2017-06-30 | (m) | (m) | $14.44M | $143.19M | (m) | (m) | $963.65M | (m) |
| 2017-03-31 | (m) | (m) | $13.41M | $147.23M | (m) | (m) | $966.09M | (m) |
| 2016-12-31 | (m) | (m) | $12.38M | $151.27M | (m) | (m) | $979.11M | (m) |
| 2016-09-30 | (m) | (m) | $6.00K | $154.61M | (m) | (m) | $976.49M | (m) |
| 2015-12-31 | (m) | (m) | $59.00K | $377.88M | (m) | (m) | $984.04M | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |